Skip to Main Content

Paper Details

Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.
Am J Cardiol
49
2018

Datasets

Release 1.2